Women's Health & Gynecology Clinical Trials Update: Week 26, 2026

Published June 26, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.

Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean

This large Phase 3 trial studied tranexamic acid to prevent heavy bleeding after cesarean delivery in women. With 11,000 participants across the United States, the trial has completed and results are available. If tranexamic acid is shown to be effective, it could lower the risk of dangerous postpartum bleeding and reduce the need for blood transfusions, improving safety for many mothers after cesarean birth.

ENDO1000 - A UK-wide Endometriosis Research Project

This ongoing study focuses on people with endometriosis, a chronic condition causing pain and other symptoms. By collecting large-scale data and samples using a mobile app and wearable devices, the research aims to better understand symptom patterns and how treatments work over time. This could lead to more personalized approaches to diagnosis and pain management for those living with endometriosis.

Optimizing the Use of Aspirin for the Prevention of Preeclampsia

This Phase 3 trial is testing whether stopping low-dose aspirin earlier in pregnancy is as effective as continuing it until later to prevent preeclampsia in women at high risk. Recruiting over 15,000 participants from Europe and Africa, the study could help reduce unnecessary aspirin use and its side effects during pregnancy, making care safer and more tailored for expectant mothers.

Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment

This study is evaluating a chatbot designed to improve genetic risk assessment for hereditary gynecologic cancers in underserved Medicaid patients. By increasing access to genetic testing recommendations, the intervention could help identify more patients at risk and support earlier prevention or treatment steps. The trial is recruiting 150 participants at four US locations.

Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation

This research is testing an artificial intelligence ultrasound tool to estimate fetal weight more accurately during pregnancy. Although not yet recruiting, the planned study of 1,000 participants across multiple countries hopes to improve prenatal care by providing better information about fetal growth. This could help doctors and families prepare for birth more effectively.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.